Indonesia Substance Use Reduction for Female Therapy (Indo-SURFT)
Behavioral4 weeks of motivational interviewing/motivational enhancement therapy (MI) followed by 8 weeks cognitive behavioral therapy (CBT) using Indo-SURFT module.
NCT Number: NCT06174714
Relapse in women was associated with depression, interpersonal stress, and relationship conflict with others when compared with men. The differences in gender profiles with substance use disorders (SUD) leads to the need for management strategies that are sensitive to each gender. This is a challenge to build a new module that can be applied continuously by collaborating CBT and several other psychosocial interventions, such as motivational enhancement therapy. The investigators compiled Indonesia Substance Use Reduction for Female Therapy (Indo-SURFT). By implementing this module, it is hoped that it can provide short and long term effects and reduce the relapse rate in women with SUD.
Trial opening soon.
Get Notified18 year–59 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 weeks of motivational interviewing/motivational enhancement therapy (MI) followed by 8 weeks cognitive behavioral therapy (CBT) using Indo-SURFT module.
Time frame: post-intervention (week 13)
Timeline Follow Back (TLFB): to assess daily use of addictive substances by writing yes/no for 28 days. This data will be collected weekly retrospectively to reduce the risk of recall bias.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
Addiction Severity Index (ASI), Indonesia version, measuring several domains: 1) Medical health (n= 11), 2) Employment/ support status (n= 24), 3 & 4) Drug/ alcohol use (n= 35), 5) Illegal activity/ legal status (n= 32), 6) Family/ social relationships (n= 38) and 7) Psychiatric health (n= 23). Lesser score indicates better outcome.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
University of Rhode Island Change Assessment (URICA), measuring motivation to change with 4 domains: 1) pre-contemplation, 2) contemplation, 3) action, and 4) maintenance. A higher score indicates a better outcome.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
Visual Analog Scale (VAS), measuring substance craving severity. Range 0 (no craving) - 100 (severe craving). A lower score indicates a better outcome.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
Self-Report Questionnaire-20 (SRQ-20), measuring non-specific psychological distress. Score range 0-20; Scores >10 classified as mental distress. A lower score indicates a better outcome.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
Personal and Social Performance (PSP), measuring social function. A lower score indicates a better outcome.
Time frame: pre-intervention (week 0), and post-intervention (week 13)
World Health Organization Quality of Life (WHOQOL), measuring individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. A higher score indicates a better outcome.
Indonesia University
Other
Effectiveness of Indo-SURFT in Reducing Addictive Substance Use in Women With Substance Use Disorders: a Pilot Study
Acronym: Indo-SURFT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07218549
Chemically-Induced Disorders, Mental Disorders
Houston, Texas, United States
View Trial DetailsNCT07735481
Chemically-Induced Disorders, Mental Disorders
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT07707115
Behavior, Bias, Implicit
Salt Lake City, Utah, United States
View Trial DetailsNCT07555145
Behavior, Chemically-Induced Disorders
Northampton, Massachusetts, United States
View Trial Details